| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-09 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-08 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-06 |